Gainers

• Inspira Technologies Oxy (NASDAQ:IINN) shares increased by 25.9% to $0.9 during Monday's pre-market session. The market value of their outstanding shares is at $25.6 million.
• Tenon Medical (NASDAQ:TNON) stock increased by 23.12% to $0.83. The company's market cap stands at $7.4 million.
• Boundless Bio (NASDAQ:BOLD) stock increased by 12.06% to $1.3. The company's market cap stands at $25.9 million.
• Intensity Therapeutics (NASDAQ:INTS) shares moved upwards by 10.97% to $0.39. The market value of their outstanding shares is at $20.9 million.
• PAVmed (NASDAQ:PAVM) shares rose 10.27% to $11.91. The market value of their outstanding shares is at $9.9 million.
• Modular Medical (NASDAQ:MODD) stock moved upwards by 10.09% to $0.48. The company's market cap stands at $33.1 million.

Losers

• Hims & Hers Health (NYSE:HIMS) stock decreased by 16.3% to $19.27 during Monday's pre-market session. The market value of their outstanding shares is at $5.2 billion.
• Estrella Immunopharma (NASDAQ:ESLA) stock declined by 13.8% to $1.25. The company's market cap stands at $54.7 million.
• Akso Health (NASDAQ:AHG) shares decreased by 10.07% to $1.34. The company's market cap stands at $818.3 million.
• Bio Green Med Solution (NASDAQ:BGMS) shares decreased by 9.01% to $1.01. The company's market cap stands at $5.4 million.
• Soligenix (NASDAQ:SNGX) stock declined by 8.85% to $1.03. The market value of their outstanding shares is at $11.3 million.
• Theriva Biologics (AMEX:TOVX) stock fell 8.64% to $0.2. The market value of their outstanding shares is at $7.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.